Anne Cambon-Thomsen
Dados Biográficos
| ID | 3761672 |
|---|---|
| NOME | Anne Cambon-Thomsen |
| PRENOMES | Anne |
| SOBRENOME | Cambon-Thomsen |
| ASSINATURA | CAMBON-THOMSEN A |
| AFILIAÇÕES | U 1027, UMR Inserm, Université Toulouse III – Paul Sabatier, France |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 7 |
| TOTAL DE CITAÇÕES | 2 |
| TOTAL COMO AUTOR | 7 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2009 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2023 |
| ÍNDICE H | 1 |
Chapitre 8. Annoncer ou pas la découverte d’anomalies non sollicitées lors d’un test génétique à séquençage haut débit
Objectif : Les nouvelles techniques de séquençage du génome permettent de nouvelles approches en génétique médicale, notamment en facilitant le diagnostic de maladies génétiques. Cependant, leur utilisation conduit également à la mise à jour d’anomalies génétiques non sollicitées. Ce type de découverte soulève des questionnements éthiques, juridiques et psychologiques. L’objectif de cette recherche de psychologie était d’étudier les différentes p…
Attitudes of French populations towards the disclosure of unsolicited findings in medical genetics
Next-generation sequencing techniques enable unsolicited findings to be detected. This discovery raises ethical questions concerning the return of these findings. Our study aimed to highlight the views of the general public, patients under supervision and health professionals concerning the acceptability of disclosing unsolicited results to patients. In total, 449 participants assessed scenarios, consisted of all combinations of three factors (pa…
From the arcane to the mundane
Genomic technologies are developing at a time when greater public involvement in research and clinical governance is sought. To this end, empirical bioethics studies, although conceptualized as academic endeavors, may draw on the inclusion of laypeople to justify informing policy. Doing so, they face similar concerns as those addressed to public consultations which cannot be termed democratic a priori and may reinforce the authority of experts. W…
Judging health risk as a function of risk factors and type of illness
We examined the extent to which lay people and health professionals are able to assess occurrence risks for multifactorial diseases. We asked 341 participants to assess the risk of developing lung cancer, coronary artery disease or rheumatoid arthritis in 16 scenarios, each featuring a combination of four factors (family history, daily alcohol intake, daily tobacco consumption and genetic test results). Participants considered all factors. Howeve…
Producing ‘Human Elements Based Medical Technologies’ in Biotech Companies
This article is based on the findings of an EU-funded qualitative research project, entitled ‘From GMP to GBP: Fostering good bioethics practices [GBP] among the European biotechnology industry’, which seeks to improve the understanding of bioethical issues through the observation of the daily practices in European biotechnology companies and proposes a methodology approaching ethical issues. The comparative study was carried out in biotech compa…
Direct-to-consumer health genetic testing services
Online availability of direct-to-consumer health genetic testing services for various diseases and behavioural traits appears to have created a business dynamic since its beginning around the turn of the millennium. What are the marketing strategies implemented by the companies commercialising these tests and the social expectations they feed on? From a quantitative and qualitative analysis of the websites offering such tests for health, it appea…
Public Health Genomics (PHG) and Public Participation
Large-scale population biobanks, which aim to collect biological tissues, personal health information, and genomic data, are being introduced worldwide with the promise of increasing knowledge on chronic diseases such as diabetes and heart disease. Experts recognize the need for public participation to address the many social, legal and ethical complexities raised by the introduction of biobanks for public health research. However many researcher…
Judging health risk as a function of risk factors and type of illness
We examined the extent to which lay people and health professionals are able to assess occurrence risks for multifactorial diseases. We asked 341 participants to assess the risk of developing lung cancer, coronary artery disease or rheumatoid arthritis in 16 scenarios, each featuring a combination of four factors (family history, daily alcohol intake, daily tobacco consumption and genetic test results). Participants considered all factors. Howeve…
Direct-to-consumer health genetic testing services
Online availability of direct-to-consumer health genetic testing services for various diseases and behavioural traits appears to have created a business dynamic since its beginning around the turn of the millennium. What are the marketing strategies implemented by the companies commercialising these tests and the social expectations they feed on? From a quantitative and qualitative analysis of the websites offering such tests for health, it appea…
Public Health Genomics (PHG) and Public Participation
Large-scale population biobanks, which aim to collect biological tissues, personal health information, and genomic data, are being introduced worldwide with the promise of increasing knowledge on chronic diseases such as diabetes and heart disease. Experts recognize the need for public participation to address the many social, legal and ethical complexities raised by the introduction of biobanks for public health research. However many researcher…
Producing ‘Human Elements Based Medical Technologies’ in Biotech Companies
This article is based on the findings of an EU-funded qualitative research project, entitled ‘From GMP to GBP: Fostering good bioethics practices [GBP] among the European biotechnology industry’, which seeks to improve the understanding of bioethical issues through the observation of the daily practices in European biotechnology companies and proposes a methodology approaching ethical issues. The comparative study was carried out in biotech compa…
Direct-to-consumer health genetic testing services
Online availability of direct-to-consumer health genetic testing services for various diseases and behavioural traits appears to have created a business dynamic since its beginning around the turn of the millennium. What are the marketing strategies implemented by the companies commercialising these tests and the social expectations they feed on? From a quantitative and qualitative analysis of the websites offering such tests for health, it appea…
From the arcane to the mundane
Genomic technologies are developing at a time when greater public involvement in research and clinical governance is sought. To this end, empirical bioethics studies, although conceptualized as academic endeavors, may draw on the inclusion of laypeople to justify informing policy. Doing so, they face similar concerns as those addressed to public consultations which cannot be termed democratic a priori and may reinforce the authority of experts. W…
Judging health risk as a function of risk factors and type of illness
We examined the extent to which lay people and health professionals are able to assess occurrence risks for multifactorial diseases. We asked 341 participants to assess the risk of developing lung cancer, coronary artery disease or rheumatoid arthritis in 16 scenarios, each featuring a combination of four factors (family history, daily alcohol intake, daily tobacco consumption and genetic test results). Participants considered all factors. Howeve…
Attitudes of French populations towards the disclosure of unsolicited findings in medical genetics
Next-generation sequencing techniques enable unsolicited findings to be detected. This discovery raises ethical questions concerning the return of these findings. Our study aimed to highlight the views of the general public, patients under supervision and health professionals concerning the acceptability of disclosing unsolicited results to patients. In total, 449 participants assessed scenarios, consisted of all combinations of three factors (pa…
Chapitre 8. Annoncer ou pas la découverte d’anomalies non sollicitées lors d’un test génétique à séquençage haut débit
Objectif : Les nouvelles techniques de séquençage du génome permettent de nouvelles approches en génétique médicale, notamment en facilitant le diagnostic de maladies génétiques. Cependant, leur utilisation conduit également à la mise à jour d’anomalies génétiques non sollicitées. Ce type de découverte soulève des questionnements éthiques, juridiques et psychologiques. L’objectif de cette recherche de psychologie était d’étudier les différentes p…
Biomedical Ethics and Regulation (5 obras) · Ethics in Clinical Research (5 obras) · Medicine (5 obras) · Political science (5 obras) · Biology (4 obras) · Law (4 obras) · Sociology (4 obras) · BRCA gene mutations in cancer (3 obras) · Psychology (3 obras) · Public relations (3 obras)